Allogene Therapeutics (ALLO)
(Delayed Data from NSDQ)
$2.89 USD
+0.04 (1.23%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $2.88 -0.01 (-0.35%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/01/2024
Time: -- |
3/2024 | $-0.39 | -3.94% |
Earnings Summary
For their last quarter, Allogene Therapeutics (ALLO) reported earnings of -$0.43 per share, beating the Zacks Consensus Estimate of $-0.47 per share. This reflects a positive earnings surprise of 8.51%. Look out for ALLO's next earnings release expected on May 01, 2024. For the next earning release, we expect the company to report earnings of -$0.39 per share, reflecting a year-over-year increase of 42.65%.
Earnings History
Price & Consensus
Zacks News for ALLO
Allogene Therapeutics (ALLO) Expected to Beat Earnings Estimates: Should You Buy?
ALLO: What are Zacks experts saying now?
Zacks Private Portfolio Services